EyePoint Pharmaceuticals, Inc. — Director's Dealing 2019

Jun 27, 2019

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: EyePoint Pharmaceuticals, Inc. (EYPT)
CIK: 0001314102
Period of Report: 2019-06-25

Reporting Person: Lurker Nancy (N/A)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2019-06-25	Restricted Stock Units	$0.00	A	411523.00	Acquired		Common Stock (411523.00)	Direct
2019-06-25	Stock Option (Right to Buy)	$2.65	A	930000.00	Acquired	2029-02-21	Common Stock (930000.00)	Direct

Footnotes

F1: The restricted stock units will vest in three ratable annual installments beginning February 21, 2020.

F2: The option to purchase vests and becomes exercisable ratably in forty-eight monthly installments which began March 21, 2019